10 Apr2015
FEATURED PRESS RELEASE: DIA EuroMeeting celebrates 50 years of pharma milestones
The 27th DIA EuroMeeting in Paris, 13-15 April 2015, will be a landmark event.
It is 50 years since the first European pharmaceutical legislation and 50 years since the founding of the European Directorate for the Quality of Medicines and HealthCare. DIA recognises these pivotal events in European healthcare with two special sessions at this year’s EuroMeeting.
Firstly, there is a Regulatory Town Hall Meeting, entitled “European Pharmaceutical Legislation at 50”. Moderated by Fernand Sauer, first executive director of the European Medicines Agency, it features speakers from the EMA, national regulatory bodies and European patient advocacy. They will discuss the benefits delivered by 50 years of European pharmaceutical legislation and how future legislation can shape innovation.
Yisheng Biopharma Co., Ltd. (Yisheng Biopharma), a biopharmaceutical company, announced that a new vaccine for the post exposure treatment of the rabies infection was entering human clinical trial after a six-year long collaboration with a number of research institutes worldwide.